This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 May;47(1):79-83.

doi: 10.1007/s10858-010-9412-1. Epub 2010 Apr 8.

Solution structure of the RBD1,2 domains from human nucleolin

Sengodagounder Arumugam¹, M Clarke Miller, James Maliekal, Paula J Bates, John O Trent, Andrew N Lane

Affiliations

PMID: 20376532
DOI: 10.1007/s10858-010-9412-1

Solution structure of the RBD1,2 domains from human nucleolin

Sengodagounder Arumugam et al. J Biomol NMR. 2010 May.

. 2010 May;47(1):79-83.

doi: 10.1007/s10858-010-9412-1. Epub 2010 Apr 8.

Authors

Sengodagounder Arumugam¹, M Clarke Miller, James Maliekal, Paula J Bates, John O Trent, Andrew N Lane

Affiliation

¹ JG Brown Cancer Center, University of Louisville, 505 South Hancock St., Louisville, KY 40202, USA.

PMID: 20376532
DOI: 10.1007/s10858-010-9412-1

No abstract available

PubMed Disclaimer

Similar articles

Solution structure of the two N-terminal RNA-binding domains of nucleolin and NMR study of the interaction with its RNA target.
Allain FH, Gilbert DE, Bouvet P, Feigon J. Allain FH, et al. J Mol Biol. 2000 Oct 20;303(2):227-41. doi: 10.1006/jmbi.2000.4118. J Mol Biol. 2000. PMID: 11023788
Contributions of the RNA-binding and linker domains and RNA structure to the specificity and affinity of the nucleolin RBD12/NRE interaction.
Finger LD, Johansson C, Rinaldi B, Bouvet P, Feigon J. Finger LD, et al. Biochemistry. 2004 Jun 8;43(22):6937-47. doi: 10.1021/bi049904d. Biochemistry. 2004. PMID: 15170331
Molecular basis of sequence-specific recognition of pre-ribosomal RNA by nucleolin.
Allain FH, Bouvet P, Dieckmann T, Feigon J. Allain FH, et al. EMBO J. 2000 Dec 15;19(24):6870-81. doi: 10.1093/emboj/19.24.6870. EMBO J. 2000. PMID: 11118222 Free PMC article.
STARD5 specific ligand binding: comparison with STARD1 and STARD4 subfamilies.
Létourneau D, Lefebvre A, Lavigne P, LeHoux JG. Létourneau D, et al. Mol Cell Endocrinol. 2013 May 22;371(1-2):20-5. doi: 10.1016/j.mce.2013.01.004. Epub 2013 Jan 19. Mol Cell Endocrinol. 2013. PMID: 23337244 Review.
Multifaceted Nucleolin Protein and Its Molecular Partners in Oncogenesis.
Ugrinova I, Petrova M, Chalabi-Dchar M, Bouvet P. Ugrinova I, et al. Adv Protein Chem Struct Biol. 2018;111:133-164. doi: 10.1016/bs.apcsb.2017.08.001. Epub 2017 Oct 6. Adv Protein Chem Struct Biol. 2018. PMID: 29459030 Review.

See all similar articles

Cited by

Identification of RSV Fusion Protein Interaction Domains on the Virus Receptor, Nucleolin.
Mastrangelo P, Chin AA, Tan S, Jeon AH, Ackerley CA, Siu KK, Lee JE, Hegele RG. Mastrangelo P, et al. Viruses. 2021 Feb 8;13(2):261. doi: 10.3390/v13020261. Viruses. 2021. PMID: 33567674 Free PMC article.
Exploring the G-Quadruplex Formation of AS1411 Derivatives.
Lourenço P, Moreira D, Miranda A, Lopes-Nunes J, Maocha I, Santos T, Ferreira PL, Sousa F, Paiva A, Cruz C. Lourenço P, et al. Molecules. 2025 Apr 8;30(8):1673. doi: 10.3390/molecules30081673. Molecules. 2025. PMID: 40333559 Free PMC article.
Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.
Fujiki H, Watanabe T, Suganuma M. Fujiki H, et al. J Cancer Res Clin Oncol. 2014 May;140(5):689-99. doi: 10.1007/s00432-014-1587-5. Epub 2014 Jan 28. J Cancer Res Clin Oncol. 2014. PMID: 24469254 Free PMC article.
Impairment of Nucleolin Activity and Phosphorylation by a Trachylobane Diterpene from Psiadia punctulata in Cancer Cells.
Bellone ML, Fiengo L, Cerchia C, Cotugno R, Bader A, Lavecchia A, De Tommasi N, Piaz FD. Bellone ML, et al. Int J Mol Sci. 2022 Sep 27;23(19):11390. doi: 10.3390/ijms231911390. Int J Mol Sci. 2022. PMID: 36232690 Free PMC article.
A peptidylic inhibitor for neutralizing expanded CAG RNA-induced nucleolar stress in polyglutamine diseases.
Zhang Q, Chen ZS, An Y, Liu H, Hou Y, Li W, Lau KF, Koon AC, Ngo JCK, Chan HYE. Zhang Q, et al. RNA. 2018 Apr;24(4):486-498. doi: 10.1261/rna.062703.117. Epub 2018 Jan 2. RNA. 2018. PMID: 29295891 Free PMC article.

See all "Cited by" articles

References

1. Mol Cancer Ther. 2006 Jul;5(7):1790-9 - PubMed
1. J Biomol NMR. 2009 Aug;44(4):213-23 - PubMed
1. J Mol Biol. 1997 Oct 17;273(1):283-98 - PubMed
1. Exp Mol Pathol. 2009 Jun;86(3):151-64 - PubMed
1. J Mol Graph. 1996 Feb;14(1):51-5, 29-32 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- The Lens - Patent Citations Database